{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T10:11:43Z","timestamp":1775902303158,"version":"3.50.1"},"reference-count":7,"publisher":"BMJ","issue":"6","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child Fetal Neonatal Ed"],"accepted":{"date-parts":[[2024,3,15]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>There is insufficient evidence to determine if non-invasive transcutaneous bilirubin (TcB) measurement can replace serum bilirubin (SBR) in assessing rebound hyperbilirubinaemia after phototherapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>To investigate if TcB can safely guide management of neonates after phototherapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Subjects<\/jats:title>\n                  <jats:p>100 well neonates \u226535 weeks\u2019 gestation who had received inpatient phototherapy.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Method<\/jats:title>\n                  <jats:p>Measurement of both helix (manufacturer\u2019s recommendation) and earlobe TcB coincidentally with routine SBR 12 hours after cessation of phototherapy. All mothers gave written informed consent.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Gestation ranged from 35<jats:sup>+0<\/jats:sup> to 41<jats:sup>+5<\/jats:sup> (median 37<jats:sup>+6<\/jats:sup>) weeks; birth weight 2018\u20134566 (median 3230) g; age 55\u2013222 (median 109) hours at testing. 86% neonates were Caucasian. Outcomes determined by SBR included restarting phototherapy (n=0), repeat SBR next day (n=29), no further routine follow-up (n=71).<\/jats:p>\n                  <jats:p>TcB and SBR measurements were unpredictably inconsistent. Helix TcB tended to underestimate SBR (mean difference 50.1 (95% CI 113.9 to -13.7) \u03bcmols\/L); for earlobe TcB mean difference was -13.4 (95% CI 46.3 to -73.2) \u03bcmols\/L (overestimate), but bias was greater over the range of mean differences. No demographic factor predicted consistency between TcB and SBR. TcB was 25% (helix) and 76% (earlobe) sensitive in predicting repeat phototherapy and\/or repeat SBR; specificities were 92% and 58%, respectively. Adding a safety margin of 120 \u03bcmols\/L to helix TcB value could have safely avoided invasive SBR measurement in 50\/98 (51%) babies.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Consistency between TcB and rebound SBR is unpredictable in well neonates <jats:underline>&gt;<\/jats:underline>35 weeks\u2019 gestation but adopting a wide safety margin has potential to reduce blood sampling. Recommencement of phototherapy is uncommon in this population.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/archdischild-2023-326145","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T01:50:22Z","timestamp":1712800222000},"page":"634-637","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Can transcutaneous bilirubinometry safely be used to monitor rebound hyperbilirubinaemia after phototherapy in neonates \u226535 weeks\u2019 gestation? A prospective, comparative study"],"prefix":"10.1136","volume":"109","clinical-trial-number":[{"clinical-trial-number":"nct04719104","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8713-7425","authenticated-orcid":false,"given":"Frances Rose","family":"Butterworth","sequence":"first","affiliation":[{"name":"Neonatal Unit, Princess Royal Maternity, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Boulton","sequence":"additional","affiliation":[{"name":"Neonatal Unit, Princess Royal Maternity, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shona","family":"Campbell","sequence":"additional","affiliation":[{"name":"Neonatal Unit, Princess Royal Maternity, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian","family":"Frew","sequence":"additional","affiliation":[{"name":"Neonatal Unit, Princess Royal Maternity, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6154-5758","authenticated-orcid":false,"given":"Helen","family":"Mactier","sequence":"additional","affiliation":[{"name":"Neonatal Unit, Princess Royal Maternity, Glasgow, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,4,10]]},"reference":[{"key":"2025090511045978000_109.6.634.1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-1919"},{"key":"2025090511045978000_109.6.634.2","unstructured":"NICE Guideline . Jaundice in newborn babies under 28 days (CG98). 2010. Available: https:\/\/www.nice.org.uk\/guidance\/cg98"},{"key":"2025090511045978000_109.6.634.3","doi-asserted-by":"publisher","DOI":"10.1159\/000442195"},{"key":"2025090511045978000_109.6.634.4","doi-asserted-by":"publisher","DOI":"10.5858\/2008-132-684-EOTBBU"},{"key":"2025090511045978000_109.6.634.5","doi-asserted-by":"publisher","DOI":"10.1179\/2046905513Y.0000000050"},{"key":"2025090511045978000_109.6.634.6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2014-1677"},{"key":"2025090511045978000_109.6.634.7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2020-000681","article-title":"Transcutaneous bilirubinometry during and after phototherapy in preterm infants: a prospective observational study","volume":"4","author":"Raba","year":"2020","journal-title":"BMJ Paediatr Open"}],"container-title":["Archives of Disease in Childhood - Fetal and Neonatal Edition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2023-326145","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,5]],"date-time":"2025-09-05T18:30:23Z","timestamp":1757097023000},"score":1,"resource":{"primary":{"URL":"https:\/\/fn.bmj.com\/lookup\/doi\/10.1136\/archdischild-2023-326145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,10]]},"references-count":7,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,10,18]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/archdischild-2023-326145"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2023-326145","relation":{},"ISSN":["1359-2998","1468-2052"],"issn-type":[{"value":"1359-2998","type":"print"},{"value":"1468-2052","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,10]]}}}